Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids.

Huang Q, Chan KY, Tobey IG, Chan YA, Poterba T, Boutros CL, Balazs AB, Daneman R, Bloom JM, Seed C, Deverman BE.

PLoS One. 2019 Nov 14;14(11):e0225206. doi: 10.1371/journal.pone.0225206. eCollection 2019.

PMID:
31725765
2.

Publisher Correction: Systemic AAV vectors for widespread and targeted gene delivery in rodents.

Challis RC, Kumar SR, Chan KY, Challis C, Beadle K, Jang MJ, Kim HM, Rajendran PS, Tompkins JD, Shivkumar K, Deverman BE, Gradinaru V.

Nat Protoc. 2019 Aug;14(8):2597. doi: 10.1038/s41596-019-0155-5.

PMID:
31312046
3.

Identification of peripheral neural circuits that regulate heart rate using optogenetic and viral vector strategies.

Rajendran PS, Challis RC, Fowlkes CC, Hanna P, Tompkins JD, Jordan MC, Hiyari S, Gabris-Weber BA, Greenbaum A, Chan KY, Deverman BE, Münzberg H, Ardell JL, Salama G, Gradinaru V, Shivkumar K.

Nat Commun. 2019 Apr 26;10(1):1944. doi: 10.1038/s41467-019-09770-1.

4.

TRIM9-Mediated Resolution of Neuroinflammation Confers Neuroprotection upon Ischemic Stroke in Mice.

Zeng J, Wang Y, Luo Z, Chang LC, Yoo JS, Yan H, Choi Y, Xie X, Deverman BE, Gradinaru V, Gupton SL, Zlokovic BV, Zhao Z, Jung JU.

Cell Rep. 2019 Apr 9;27(2):549-560.e6. doi: 10.1016/j.celrep.2018.12.055.

5.

Systemic AAV vectors for widespread and targeted gene delivery in rodents.

Challis RC, Ravindra Kumar S, Chan KY, Challis C, Beadle K, Jang MJ, Kim HM, Rajendran PS, Tompkins JD, Shivkumar K, Deverman BE, Gradinaru V.

Nat Protoc. 2019 Feb;14(2):379-414. doi: 10.1038/s41596-018-0097-3. Erratum in: Nat Protoc. 2019 Aug;14(8):2597.

PMID:
30626963
6.

Gene therapy for neurological disorders: progress and prospects.

Deverman BE, Ravina BM, Bankiewicz KS, Paul SM, Sah DWY.

Nat Rev Drug Discov. 2018 Oct;17(10):767. doi: 10.1038/nrd.2018.158. Epub 2018 Sep 12.

PMID:
30206384
7.

Gene therapy for neurological disorders: progress and prospects.

Deverman BE, Ravina BM, Bankiewicz KS, Paul SM, Sah DWY.

Nat Rev Drug Discov. 2018 Sep;17(9):641-659. doi: 10.1038/nrd.2018.110. Epub 2018 Aug 10. Review. Erratum in: Nat Rev Drug Discov. 2018 Oct;17(10):767.

PMID:
30093643
8.

The Neuropeptide Tac2 Controls a Distributed Brain State Induced by Chronic Social Isolation Stress.

Zelikowsky M, Hui M, Karigo T, Choe A, Yang B, Blanco MR, Beadle K, Gradinaru V, Deverman BE, Anderson DJ.

Cell. 2018 May 17;173(5):1265-1279.e19. doi: 10.1016/j.cell.2018.03.037.

9.

Viral Strategies for Targeting the Central and Peripheral Nervous Systems.

Bedbrook CN, Deverman BE, Gradinaru V.

Annu Rev Neurosci. 2018 Jul 8;41:323-348. doi: 10.1146/annurev-neuro-080317-062048. Epub 2018 Apr 25. Review.

PMID:
29709207
10.

Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems.

Chan KY, Jang MJ, Yoo BB, Greenbaum A, Ravi N, Wu WL, Sánchez-Guardado L, Lois C, Mazmanian SK, Deverman BE, Gradinaru V.

Nat Neurosci. 2017 Aug;20(8):1172-1179. doi: 10.1038/nn.4593. Epub 2017 Jun 26.

11.

Global Representations of Goal-Directed Behavior in Distinct Cell Types of Mouse Neocortex.

Allen WE, Kauvar IV, Chen MZ, Richman EB, Yang SJ, Chan K, Gradinaru V, Deverman BE, Luo L, Deisseroth K.

Neuron. 2017 May 17;94(4):891-907.e6. doi: 10.1016/j.neuron.2017.04.017.

12.

Corrigendum: Better Targeting, Better Efficiency for Wide-Scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP.B.

Jackson KL, Dayton RD, Deverman BE, Klein RL.

Front Mol Neurosci. 2016 Dec 22;9:154. doi: 10.3389/fnmol.2016.00154. eCollection 2016.

13.

Better Targeting, Better Efficiency for Wide-Scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP.B.

Jackson KL, Dayton RD, Deverman BE, Klein RL.

Front Mol Neurosci. 2016 Nov 4;9:116. eCollection 2016. Erratum in: Front Mol Neurosci. 2016 Dec 22;9:154.

14.

Mapping a multiplexed zoo of mRNA expression.

Choi HM, Calvert CR, Husain N, Huss D, Barsi JC, Deverman BE, Hunter RC, Kato M, Lee SM, Abelin AC, Rosenthal AZ, Akbari OS, Li Y, Hay BA, Sternberg PW, Patterson PH, Davidson EH, Mazmanian SK, Prober DA, van de Rijn M, Leadbetter JR, Newman DK, Readhead C, Bronner ME, Wold B, Lansford R, Sauka-Spengler T, Fraser SE, Pierce NA.

Development. 2016 Oct 1;143(19):3632-3637.

15.

Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain.

Deverman BE, Pravdo PL, Simpson BP, Kumar SR, Chan KY, Banerjee A, Wu WL, Yang B, Huber N, Pasca SP, Gradinaru V.

Nat Biotechnol. 2016 Feb;34(2):204-9. doi: 10.1038/nbt.3440. Epub 2016 Feb 1.

16.

Whole-body tissue stabilization and selective extractions via tissue-hydrogel hybrids for high-resolution intact circuit mapping and phenotyping.

Treweek JB, Chan KY, Flytzanis NC, Yang B, Deverman BE, Greenbaum A, Lignell A, Xiao C, Cai L, Ladinsky MS, Bjorkman PJ, Fowlkes CC, Gradinaru V.

Nat Protoc. 2015 Nov;10(11):1860-1896. doi: 10.1038/nprot.2015.122. Epub 2015 Oct 22.

17.

Single-cell phenotyping within transparent intact tissue through whole-body clearing.

Yang B, Treweek JB, Kulkarni RP, Deverman BE, Chen CK, Lubeck E, Shah S, Cai L, Gradinaru V.

Cell. 2014 Aug 14;158(4):945-958. doi: 10.1016/j.cell.2014.07.017. Epub 2014 Jul 31.

18.

Control of cellular Bcl-xL levels by deamidation-regulated degradation.

Dho SH, Deverman BE, Lapid C, Manson SR, Gan L, Riehm JJ, Aurora R, Kwon KS, Weintraub SJ.

PLoS Biol. 2013;11(6):e1001588. doi: 10.1371/journal.pbio.1001588. Epub 2013 Jun 25.

19.

Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination.

Deverman BE, Patterson PH.

J Neurosci. 2012 Feb 8;32(6):2100-9. doi: 10.1523/JNEUROSCI.3803-11.2012.

20.

Cytokines and CNS development.

Deverman BE, Patterson PH.

Neuron. 2009 Oct 15;64(1):61-78. doi: 10.1016/j.neuron.2009.09.002. Review.

21.

Chronoregulation by asparagine deamidation.

Weintraub SJ, Deverman BE.

Sci STKE. 2007 Oct 23;2007(409):re7.

PMID:
17957089
22.

Resistance to antineoplastic therapy. The oncogenic tyrosine kinase-Bcl-x(L) axis.

Weintraub SJ, Manson SR, Deverman BE.

Cancer Cell. 2004 Jan;5(1):3-4. Review.

23.

Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage.

Deverman BE, Cook BL, Manson SR, Niederhoff RA, Langer EM, Rosová I, Kulans LA, Fu X, Weinberg JS, Heinecke JW, Roth KA, Weintraub SJ.

Cell. 2002 Oct 4;111(1):51-62. Erratum in: Cell. 2003 Nov 14;115(4):503.

24.

E2F is required to prevent inappropriate S-phase entry of mammalian cells.

He S, Cook BL, Deverman BE, Weihe U, Zhang F, Prachand V, Zheng J, Weintraub SJ.

Mol Cell Biol. 2000 Jan;20(1):363-71.

Supplemental Content

Loading ...
Support Center